Adamantane-derivatives in the prevention and treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/232, 167/233

A61K 31/13 (2006.01) A47F 7/08 (2006.01)

Patent

CA 2014453

Use of an adamantane derivative of the general formula (see above formula) wherein R1 and R2 are identical or different, representing hydrogen or a straight or branched alkyl group of 1 to 6 C atoms or, in conjunction with N, a heterocyclic group with 5 or 6 ring C atoms; wherein R3 and R4 are identical or different, being selected from hydrogen, a straight or branched alkyl group of 1 to 6 C atoms, a cycloalkyl group with or 6 C atoms, and phenyl; wherein R5 is hydrogen or a straight or branched C1 - C6 alkyl group, or a pharmaceutically-acceptable salt thereof, for the prevention or treatment of cerebral ischemia.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Adamantane-derivatives in the prevention and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adamantane-derivatives in the prevention and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adamantane-derivatives in the prevention and treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1658017

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.